The Society For Biomaterials (SFB) has recognized Laura Suggs with their 2022 Clemson Award for Contributions in Literature. The award recognizes an individual who has made a significant contribution to the literature on the science or technology of biomaterials.
Laura Suggs, a professor in the Department of Biomedical Engineering who holds the Zarrow Centennial Professorship in Engineering, develops clinically relevant and robust biomaterial platforms for characterizing, modeling, and treating disease and injury in the areas of ischemic and inflammatory disease as well as cancer.
“Laura’s broad impact on the biomaterials community was with her work designing and applying poly(ethelyne glycol) (PEG) modified fibrin gels for a variety of applications,” said William Wagner, Distinguished Professor of Surgery, Chemical Engineering, and Bioengineering at the University of Pittsburgh, in his nomination.
“These materials often referred to as PEGylated fibrin, provided a ready means to manipulate fibrin gel mechanical properties as well as to covalently link active biomolecules into the fibrin scaffold. Laura established herself as the leading researcher in this field, and she contributed both excellent scholarship and innovation with her many publications on this topic. ”Suggs, who is also a professor in the Department of Oncology in the Dell Medical School, has received additional recognitions as a fellow of the Royal Society of Chemistry and the American Institute for Medical and Biological Engineering. In addition to SFB, she holds membership in professional societies such as the American Institute of Chemical Engineers, Biomedical Engineering Society, and the International Society for Stem Cell Research.
The Society For Biomaterials (SFB), is a multidisciplinary society of academic, healthcare, governmental and business professionals dedicated to promoting advancements in all aspects of biomaterials science, education and professional standards to enhance human health and quality of life.Members include professionals who have experience in numerous sectors of the biomaterials field, ranging from clinicians and researchers to medical device manufacturers and students studying biomaterials.
One of the defining aspects of SFB is its commitment to bridging the gap between academic research and its application within an industry setting to advance the biomaterials field and lead to innovations in research, patient care and policy.
